Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®- and placebo-controlled trial (BRIDGE) | Synapse
August 12, 2016Open Access
Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®- and placebo-controlled trial (BRIDGE)
Key Points
Key points are not available for this paper at this time.
Abstract
LAS41008 (DMF) is effective in the treatment of adults with moderate-to-severe chronic plaque psoriasis.